Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders [PDF]
Ross L. Levine, Gerlinde Wernig
openalex +1 more source
Identification of the JAK2 V617F Mutation in Chronic Myeloproliferative Disorders Using FRET Probes and Melting Curve Analysis [PDF]
Gurunathan Murugesan+6 more
openalex +1 more source
NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin. [PDF]
Haissaguerre M+5 more
europepmc +1 more source
JAK2V617F mutation in leukaemic transformation of philadelphia‐negative chronic myeloproliferative disorders [PDF]
Davide Rossi+8 more
openalex +1 more source
Back to biology: new insights on inheritance in myeloproliferative disorders. [PDF]
Braunstein EM, Moliterno AR.
europepmc +1 more source
FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders. [PDF]
Ozdemirkiran FG+6 more
europepmc +1 more source
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]
Abboud, Camille N.
core +1 more source
The kinetics of clonal dominance in myeloproliferative disorders
Sandra N. Catlin+2 more
openalex +2 more sources